Adhera   Report issue

For profit Phase 2
Founded: City of Industry CA United States (1983)
Status: Left NME R&D (2019)

Organization Overview

First Clinical Trial
None
First Marketed Drug
2015
perindopril (aceon)
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ADHERA | Adhera Health, Inc. | MARINA BIOTECH

Active Ingredients

Marketed Drugs (2)

amlodipine (norvasc) (2015)

perindopril (aceon) (2015)

Drugs in Phase 2 Trials (5)

Key: Adhera (0) Acquired (5)

insulin human (humulin) (1 trial)

insulin lispro (humalog) (1 trial)

pyy 3-36 (1 trial)

sibutramine (meridia) (1 trial)

teriparatide (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 3
  • # of Trial APIs: 5